🇺🇸 FDA
Company

Cardiol

Cardiol Therapeutics

CRDL biotech USA

Quick answer

Cardiol is a biotech company (CRDL) headquartered in OAKVILLE, A6, USA with 3 tracked pipeline programs.

Pipeline (3)

project

Cannabidiol, pharmaceutically produced with < 5 ppm THC

COVID-19

Phase 3 · small_molecule · terminated

1 trials project

CardiolRx

Recurrent Pericarditis

Phase 3 · small_molecule · active

2 trials project

CardiolRx

Acute Myocarditis

Phase 2 · small_molecule · completed

1 trials

Patents (8)

patent

US 12419888

Methods of treating elevated plasma cholesterol

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11844771

Methods of treating acute respiratory distress syndrome using colchicine

Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11795434

Engineered stem cells and cellular products produced and secreted by such cells,

Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11639490

Device and method for producing and purifying exosomes

Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11529390

PCSK9 inhibitory polypolypeptides and methods of use

Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11400063

Early administration of low-dose colchicine after myocardial infarction

Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10788490

Dried cellulose-treated tissue for in-vitro complement activation assays and dia

Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9789134

Agent for the selective adjustment of blood lipids

Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)